Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023
   PCE(x) 51.24-970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is 51.24 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202551.24
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 51.24
Positive
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹69.8 Cr -3.1% 35.5% -39.9% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,392.2 Cr 4.2% 20.5% -10.8% Stock Analytics
KIRI INDUSTRIES ₹2,733.8 Cr 0.8% 15% -27% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,524.3 Cr 2% 1.9% -30.7% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,262.3 Cr 1.6% 22.1% 59.6% Stock Analytics
BODAL CHEMICALS ₹845.2 Cr -2% 23.6% 2% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-3.1%

35.5%

-39.9%

SENSEX

-0.4%

7.1%

-4%


You may also like the below Video Courses